Records containing: Tuberous Sclerosis Complex
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-22A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
-
CLINICAL_TRIALS study record update · 2026-04-02An Open-label, Multi-center Long-term Safety Roll-over Study in Patients With Tuberous Sclerosis Complex (TSC) and Refractory Seizures Who Are Judged by the Investigator to Benefit From Continued Treatment With Everolimus After Completion of Study CRAD001M2304.
-
CLINICAL_TRIALS study record update · 2026-04-01A Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms of Radiprodil in Patients With Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD) Type II
-
CLINICAL_TRIALS study record update · 2026-02-17Observational, Prospective, Multicenter Study of Epidyolex® (Cannabidiol CBD 100 mg/ml) Oral Solution, as Adjunctive Treatment for Seizures Associated With Lennox- Gastaut Syndrome (LGS), Dravet Syndrome (DS) and Tuberous Sclerosis Complex (TSC)
-
CLINICAL_TRIALS study record update · 2026-01-23Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-22Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
-
CLINICAL_TRIALS study record update · 2026-01-21Feasibility Study of [11C]Acetate Positron Emission Tomography (PET) as an Indicator of Early Response to Rapamycin in Lymphangioleiomyomatosis (LAM) Patients
-
CLINICAL_TRIALS study record update · 2025-10-01A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE)
-
CLINICAL_TRIALS study record update · 2025-07-11A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC)
-
CLINICAL_TRIALS study record update · 2025-06-04A Phase 2B, Multicenter, 30-week, Prospective, Cross-over, Double-blind, Randomized, Placebo-controlled Study Followed by a 52-Week Open-label Extension Study to Evaluate the Efficacy and Safety of Basimglurant Adjunctive to Ongoing Anticonvulsive Therapy in Children, Adolescents, and Young Adults With Uncontrolled Seizures Associated With Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2025-01-23Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning
-
CLINICAL_TRIALS study record update · 2025-01-17Clinical Evaluation of the Effectiveness and Safety of Resective Epilepsy Surgery for Tuberous Sclerosis Complex Related Epilepsy
-
CLINICAL_TRIALS study record update · 2024-12-19Clinical Evaluation of the Effectiveness and Safety of Vagus Nerve Stimulation for Tuberous Sclerosis Complex Related Epilepsy
-
CLINICAL_TRIALS study record update · 2024-11-22Placebo-controlled Comparative Study of NPC-12Y Gel in Patients With Skin Lesions Associated With Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2024-08-19Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Randomized, Double-blind, Placebo-controlled Seizure Prevention Clinical Trial for Infants With TSC
-
CLINICAL_TRIALS study record update · 2024-05-16Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
-
CLINICAL_TRIALS study record update · 2024-02-14Randomised Controlled Trial of Acceptance and Commitment Therapy in Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2024-02-08Randomized, Placebo-controlled, Double-blind and Double-dummy Clinical Trial Comparing the Safety, Tolerability, and Efficacy of Vigabatrin and Rapamycin in a Preventive Treatment of Infants With Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2024-01-05Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
-
CLINICAL_TRIALS study record update · 2023-11-29Studies in Patients With Rett Syndrome, Tuberous Sclerosis Complex, Neurofibromatoses, and Other Neurodevelopmental Disorders
-
CLINICAL_TRIALS study record update · 2023-08-08Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With TSC
-
CLINICAL_TRIALS study record update · 2023-03-29Study of New Potential Biomarkers of Lymphangioleiomyomatosis: Determination of Cathepsin K, Cystatin C, Collagen Telopeptides and Chondroitin Sulfates
-
CLINICAL_TRIALS study record update · 2022-07-14A Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P, CBD) as Add-on Therapy in Patients With Tuberous Sclerosis Complex Who Experience Inadequately-controlled Seizures
-
CLINICAL_TRIALS study record update · 2021-09-01A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
-
CLINICAL_TRIALS study record update · 2021-03-29Rapalogues for Autism Phenotype in TSC: A Feasibility Study